Clinical Trial Update: SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating SHR-1316 in combination with chemotherapy for advanced esophageal squamous cell cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• SHR-1316

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Advanced Esophageal Squamous Cell Cancer | Phase 2 | Status: UNKNOWN